In ₹ Crore except Per Share Latest Annual	TTKHLTCARE FY26	DCMSHRIRAM FY26	BALMLAWRIE FY26	GODREJIND FY26	Peer Average
Valuation — at last close
P/E	21.08×	17.54×	◆ 9.25×	24.90×	17.23× +22%
P/B	1.24×	1.95×	◆ 1.24×	2.76×	1.98× -37%
EV/EBITDA	29.61×	11.33×	◆ 6.25×	36.81×	18.13× +63%
Market Cap	₹1,385 Cr	₹15,050 Cr	₹2,558 Cr	₹30,885 Cr	₹16,164 Cr -91%
Growth
Revenue CAGR 3Y	5.74%	5.70%	5.38%	◆ 9.93%	7.00% -18%
Revenue CAGR 5Y	6.14%	11.42%	11.48%	◆ 18.96%	13.95% -56%
Net Income CAGR 3Y	-53.17%	-2.05%	17.27%	◆ 19.30%	11.51% -562%
Revenue YoY (latest Q)	14.65%	20.93%	10.00%	◆ 22.16%	17.70% -17%
Net Income YoY (latest Q)	◆ 993.73%	-33.42%	5.32%	-27.85%	-18.65% +5428%
Profitability
EBITDA Margin	3.05%	10.50%	◆ 12.91%	10.08%	11.16% -73%
Net Income Margin	7.66%	6.00%	9.95%	◆ 10.85%	8.93% -14%
Return on Common Equity	6.03%	11.60%	◆ 13.70%	11.63%	12.31% -51%
Return on Capital Employed	1.59%	10.00%	◆ 11.21%	4.01%	8.41% -81%
Return on Assets	5.03%	6.37%	◆ 8.46%	2.25%	5.69% -12%
Credit & Quality
Total Debt/Equity	◆ 0.02×	0.36×	0.04×	2.20×	0.87× -98%
Interest Coverage	5.95×	5.66×	◆ 8.21×	0.70×	4.86× +23%
Scale — latest FY
Revenue / Total Income	₹857 Cr	₹14,264 Cr	₹2,717 Cr	₹22,237 Cr	₹13,073 Cr -93%
Net Income	₹65.7 Cr	₹856 Cr	₹270 Cr	₹2,412 Cr	₹1,179 Cr -94%
Total Assets	₹1,329 Cr	₹14,137 Cr	₹3,349 Cr	₹1.26L Cr	₹47,930 Cr -97%
EPS	₹46.48	₹54.73	₹16.18	₹36.83	₹35.91 +29%
Book Value per Share	₹788.98	₹491.99	₹120.99	₹331.84	₹314.94 +151%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.